Cambridge Investment Research Advisors, Inc. Merus N.V. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Merus N.V. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 11,747 shares of MRUS stock, worth $624,118. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,747Holding current value
$624,118% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRUS
# of Institutions
196Shares Held
59.2MCall Options Held
345KPut Options Held
222K-
Rtw Investments, LP New York, NY4.17MShares$222 Million4.12% of portfolio
-
Commodore Capital LP New York, NY3.2MShares$170 Million16.98% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.75MShares$146 Million3.41% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.4MShares$127 Million0.34% of portfolio
-
Samlyn Capital, LLC New York, NY2.32MShares$123 Million2.45% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.44B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...